← Eichor
Condition: Erythroleukoplakia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Erythroleukoplakia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pembrolizumab in Treating Participants With Leukoplakia
Phase 2 · 3 location(s) · Jonsson Comprehensive Cancer Center · NCT03603223Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment
Phase N/A · 3 location(s) · Proteocyte Diagnostics Inc. · NCT04622462Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™
Phase N/A · 5 location(s) · Proteocyte Diagnostics Inc. · NCT05853783
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.